Apto‑Gen Limited develops and supplies biotechnology products, including lyophilisation solutions, R Sign up to read more
No filings found for this company.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| DR RORY JAMES O'NEILL | ORDINARY | 571 | 57.1% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
1 more shareholder on file , sign up free to see.
Companies with the most similar business descriptions.
Capital raised per employee divides the equity APTO-GEN LIMITED raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.
These are the directors and secretaries who have left APTO-GEN LIMITED. A resignation is filed with Companies House on form TM01 and the date below is the date the officer's appointment ended, not the date it was filed. Departures matter for reading a company's history: a founder leaving shortly after a funding round, or several directors resigning at once, is often the visible trace of a change of control or a restructure.